Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. | J Hematol Oncol | 2022 | 35585567 | PubTator, text mining | PubMed |
| Single-cell RNA Sequencing Uncovered the Involvement of an Endothelial Subset in Neutrophil Recruitment in Chemically Induced Rat Pulmonary Inflammation. | Int J Med Sci | 2022 | 35582423 | PubTator, text mining | PubMed |
| Tumor Suppressive Role of MUC6 in Wilms Tumor via Autophagy-Dependent β-Catenin Degradation. | Front Oncol | 2022 | 35574418 | PubTator, text mining | PubMed |
| CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma. | Front Oncol | 2022 | 35574409 | PubTator, text mining | PubMed |
| Hypoxia as a Modulator of Inflammation and Immune Response in Cancer. | Cancers (Basel) | 2022 | 35565420 | PubTator, text mining | PubMed |
| Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives. | Cancers (Basel) | 2022 | 35565264 | PubTator, text mining | PubMed |
| Potential Biomarkers and Drugs for Nanoparticle-Induced Cytotoxicity in the Retina: Based on Regulation of Inflammatory and Apoptotic Genes. | Int J Environ Res Public Health | 2022 | 35565057 | PubTator, text mining | PubMed |
| Atypical B cells up-regulate costimulatory molecules during malaria and secrete antibodies with T follicular helper cell support. | Sci Immunol | 2022 | 35559666 | PubTator, text mining | PubMed |
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
| Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. | J Clin Transl Hepatol | 2022 | 35528987 | PubTator, text mining | PubMed |
| IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer. | J Oncol | 2022 | 35528245 | PubTator, text mining | PubMed |
| Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson's Disease. | Front Neurosci | 2022 | 35516803 | PubTator, text mining | PubMed |
| Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer. | Onco Targets Ther | 2022 | 35509453 | PubTator, text mining | PubMed |
| Single-cell analysis of human testis aging and correlation with elevated body mass index. | Dev Cell | 2022 | 35504286 | PubTator, text mining | PubMed |
| Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways. | NPJ Syst Biol Appl | 2022 | 35501398 | PubTator, text mining | PubMed |
Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features. | J Immunol | 2022 | 35500934 | PubTator, text mining | PubMed |
| Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers. | Mol Cancer Ther | 2022 | 35500016 | PubTator, text mining | PubMed |
| Identification of key candidate genes and biological pathways in the synovial tissue of patients with rheumatoid arthritis. | Exp Ther Med | 2022 | 35495609 | PubTator, text mining | PubMed |
| A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies. | Front Immunol | 2022 | 35493522 | PubTator, text mining | PubMed |
| B cells in autoimmune hepatitis: bystanders or central players? | Semin Immunopathol | 2022 | 35488094 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=47